Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets (Unaudited)

v2.4.0.6
Balance Sheets (Unaudited) (USD $)
Mar. 31, 2013
Sep. 30, 2012
Balance Sheets    
Cash $ 1,765,208 $ 2,632,413
Prepaid expenses 208,838 218,242
Total Current Assets 1,974,046 2,850,655
EQUIPMENT, net 38,383 43,111
OTHER ASSETS    
Patent costs, net 584,866 623,654
TOTAL ASSETS 2,597,295 3,517,420
Accounts payable and accrued expenses 314,293 300,462
Notes payable 3,643 22,037
Derivative liabilities    768,696
Total Current Liabilities 317,936 1,091,195
TOTAL LIABILITIES 317,936 1,091,195
Preferred stock, Series B; 6,000,000 shares authorized, at $0.0001 par value, 5,444,447 and 5,583,336 shares issued and outstanding, respectively 544 558
Common stock; 180,000,000 shares authorized, at $0.0001 par value, 49,701,488 and 47,258,686 shares issued and outstanding, respectively 4,970 4,726
Additional paid-in capital 33,314,851 30,963,228
Stock subscription receivable    (11,891)
Accumulated deficit (21,628,748) (21,628,748)
Deficit accumulated during the development stage (9,412,258) (6,901,648)
Total Stockholders' Equity (Deficit) 2,279,359 2,426,225
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 2,597,295 $ 3,517,420